Ibuprofen Eg (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By reducing prostaglandin synthesis, ibuprofen decreases the sensitisation of pain receptors, lowers the hypothalamic set‑point for temperature, and limits the inflammatory response.

The appropriate dose of Ibuprofen Eg is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and response to therapy. Dosage recommendations are provided on the product label and must be followed as directed by a qualified healthcare professional.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. Generally, ibuprofen is avoided in the third trimester because of potential fetal cardiovascular effects. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk. Professional guidance is essential.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Ibuprofen shares the core mechanism of COX inhibition with other NSAIDs such as naproxen and diclofenac, but it has a relatively shorter half‑life, which may allow for flexible dosing. Its safety profile is comparable, though individual tolerability varies; some patients may experience fewer gastrointestinal side effects with ibuprofen versus certain alternatives.

Ibuprofen Eg should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Ibuprofen Eg is intended for oral administration. Tablets should be swallowed whole with a full glass of water, preferably with food or milk to minimise gastrointestinal irritation. The exact method of intake should follow the prescribing clinician’s instructions.

Serious risks include gastrointestinal bleeding or ulceration, acute renal injury, severe allergic reactions such as anaphylaxis, and increased risk of cardiovascular events like myocardial infarction or stroke, especially with high‑dose or prolonged use. Patients should be monitored for these events and discontinue use if they occur.

Ibuprofen Eg is contraindicated in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, and in the third trimester of pregnancy. Patients with significant renal or hepatic impairment should also avoid use unless specifically directed by a physician.